ClinicalTrials.gg
Not yet recruitingNCT06980467Updated May 20, 2025

Evaluation of AI-Generated Clinical Advice by Physicians

An interventional study of Large Language Model in Artificial Intelligence (AI), sponsored by Tsinghua University. Not yet recruiting at 2 sites in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-20.

Sponsored by Tsinghua University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study examines how artificial intelligence systems interact with medical professionals. Researchers will compare physician responses to different AI-generated outputs in simulative medical scenarios.

02

Conditions studied

  • Artificial Intelligence (AI)
03

In context

Lead sponsor

Tsinghua University is the lead sponsor of 28 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years old;
  • Licensed physician or medical professional qualified to perform clinical evaluations;
  • Willing to sign and commit time to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Unable to dedicate sufficient time to complete the study tasks;
  • Unable or unwilling to understand and follow study instructions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
8 participants (estimated)

Study arms

  • No intervention
    control group

    Participants evaluate clinical recommendations generated by Language Model A (LLM-A), with subsequent assessments of communication style characteristics using rating scales.

  • Experimental
    intervention group

    Participants evaluate clinical recommendations generated by Language Model B (LLM-B), followed by evaluations of communication style characteristics through metric instruments.

    Other: Large Language Model

Interventions

  • OtherLarge Language Model

    An artificial intelligence system generating clinical recommendations using prompts, designed to simulate clinical advisory outputs. The protocol focuses on structured medical language generation.

06

What researchers measure

Primary outcomes

  1. Physician Response to AI-Generated Medical Content

    Participants will rate their level of agreement with AI-generated clinical suggestions presented in simulated medical scenarios. Responses will be recorded using a standardized rating scale (range 1-5, where higher scores indicate better agreement).

    Time frame: Through study completion, an average of 1 week

Secondary outcomes

  1. Physician Perception of Communication Quality in AI-Generated Content

    Participants will assess the communication style of AI-generated content, focusing on factors such as empathy. Ratings will be collected using a standardized 5-point scale (range 1-5, where higher scores reflect higher perceived quality).

    Time frame: Through study completion, an average of 1 week

07

Study locations

2 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2025; primary completion for May 2025, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2025
First posted
May 20, 2025
StartEst.
May 15, 2025
Primary completionEst.
May 22, 2025
CompletionEst.
May 23, 2025
Last update
May 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06980467
Lead sponsor
Tsinghua University
Responsible party
Tien Yin Wong (Vice-Provost and Senior Vice-Chancellor, Tsinghua University) — Principal investigator
First posted
May 20, 2025
Start date
May 15, 2025 (estimated)
Primary completion
May 22, 2025 (estimated)
Completion
May 23, 2025 (estimated)
Last update
May 20, 2025

Study contacts

Yixiao Jin
Contact
jin-yx24@mails.tsinghua.edu.cn
+86 17721026692

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion